Glossary

Center for Biologics Evaluation and Research (CBER)

The Center for Biologics Evaluation and Research (CBER) is the division of FDA that is responsible for the licensing and regulation of biologic drug products. These are pharmaceuticals that have biologic systems as their origin, such as vaccines, blood products and genetically engineered formulations.

Resources

Take advantage of the knowledge and best practices gained from more than 20 years of research, innovation and development for the health and life sciences sectors.